Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Plexpress Announces Partner Programs for CRO’s to Comply with ADME-Tox Regulatory GuidelinesEMA and FDA recommend mRNA testing in ADME-Tox studies for superior sensitivity
By: Plexpress Plexpress has developed two ADME-Tox screening services for CROs to ensure compliance with regulatory guidelines. For the early screening of compounds of interest, the TRACPACK CYP+ mRNA (http://www.plexpress.com/ TRAC’s unique multiplexing with high sample throughput fills the gap between microarrays and traditional targeted approaches such as qPCR, offering numerous time, cost and accuracy benefits to alternative methods. Plexpress is offering two easy ways for CRO’s to incorporate TRAC into their workflow. The Plexpress Partner Program, an outsourced service which is ideal for small to medium throughput, and the Plexpress Licensing Program suited to a higher throughput with TRAC assays undertaken in-house by the CRO. Dr. Jari Rautio, CEO of Plexpress, said: “In light of recent recommendations, drug companies are requesting mRNA data for CYP targets to fulfill regulatory guidelines. Our TRAC CRO services and products have been designed to fulfill this exact need and are highly attractive tools thanks to the numerous benefits (http://www.plexpress.com/ To find out more about the options and benefits of TRAC in your workflow please visit the company’s CRO page (http://www.plexpress.com/ For general information please visit the Plexpress website at www.plexpress.com End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|